Fig. 1From: α-NETA down-regulates CMKLR1 mRNA expression in ileum and prevents body weight gains collaborating with ERK inhibitor PD98059 in turn to alleviate hepatic steatosis in HFD-induced obese mice but no impact on ileal mucosal integrity and steatohepatitis progressionshows α-NETA reduced the body weight, and the body weights further decreased in group NETA + PD, with significant differences compared with group HFDBack to article page